PurposeThe purpose of this study was to investigate factors impacting transplant-free survival among infants with biliary atresia.MethodsA multi-institutional, retrospective cohort study was performed at nine tertiary-level children's hospitals in the United States. Infants who underwent Kasai portoenterostomy (KP) from January 2009 to May 2017 were identified. Clinical characteristics included age at time of KP, steroid use, surgical approach, liver pathology, and surgeon experience. Likelihood of transplant-free survival (TFS) was evaluated using logistic regression, adjusting for patient and surgeon-level factors. Secondary outcomes at 1 year included readmission, cholangitis, reoperation, mortality, and biliary clearance.ResultsOverall,...
Kasai procedure (KP) and liver transplantation (LT) represent the only therapeutic options for patie...
Biliary atresia is the commonest cause of pathological jaundice in infants. The aetiology and pathog...
Biliary atresia (BA) is an infantile cholestatic disease of progressive obliterative cholangiopathy ...
Objective: The Kasai portoenterostomy has been accepted as the primary therapeutic treatment for bil...
OBJECTIVE: The prognosis of patients with biliary atresia undergoing Kasai portoenterostomy is relat...
OBJECTIVES: The prognosis of hepatoportoenterostomy (the Kasai operation) for biliary atresia worsen...
Biliary atresia is the most frequent cause of chronic cholestasis in infants. When left untreated, t...
Biliary atresia (BA) remains one of the most challenging conditions in paediatric surgery. It has se...
Kasai portoenterostomy has been the treatment of choice for neonates with biliary atresia since its ...
The introduction of Kasai portoenterostomy has dramatically improved the management and survival of ...
Surgical treatment of biliary atresia (BA) is still based on sequential strategy with Kasai hepatopo...
Aim:To estimate the incidence of Biliary Atresia(BA) amongst Neonatal Cholestatic Syndromes (NCS) an...
BACKGROUND: Increased age at surgery has a negative impact on results of the Kasai operation for bil...
The purpose of this study is to review the short-term outcome of patients with biliary atresia (BA) ...
The Korean Association of Pediatric Surgeons (KAPS) performed the second nationwide survey on biliar...
Kasai procedure (KP) and liver transplantation (LT) represent the only therapeutic options for patie...
Biliary atresia is the commonest cause of pathological jaundice in infants. The aetiology and pathog...
Biliary atresia (BA) is an infantile cholestatic disease of progressive obliterative cholangiopathy ...
Objective: The Kasai portoenterostomy has been accepted as the primary therapeutic treatment for bil...
OBJECTIVE: The prognosis of patients with biliary atresia undergoing Kasai portoenterostomy is relat...
OBJECTIVES: The prognosis of hepatoportoenterostomy (the Kasai operation) for biliary atresia worsen...
Biliary atresia is the most frequent cause of chronic cholestasis in infants. When left untreated, t...
Biliary atresia (BA) remains one of the most challenging conditions in paediatric surgery. It has se...
Kasai portoenterostomy has been the treatment of choice for neonates with biliary atresia since its ...
The introduction of Kasai portoenterostomy has dramatically improved the management and survival of ...
Surgical treatment of biliary atresia (BA) is still based on sequential strategy with Kasai hepatopo...
Aim:To estimate the incidence of Biliary Atresia(BA) amongst Neonatal Cholestatic Syndromes (NCS) an...
BACKGROUND: Increased age at surgery has a negative impact on results of the Kasai operation for bil...
The purpose of this study is to review the short-term outcome of patients with biliary atresia (BA) ...
The Korean Association of Pediatric Surgeons (KAPS) performed the second nationwide survey on biliar...
Kasai procedure (KP) and liver transplantation (LT) represent the only therapeutic options for patie...
Biliary atresia is the commonest cause of pathological jaundice in infants. The aetiology and pathog...
Biliary atresia (BA) is an infantile cholestatic disease of progressive obliterative cholangiopathy ...